BZYR

 
Common Stock SEC Reporting - Current
OTC Pink Current Information
Contact Info
  • 9432 Katy Freeway
  • Suite 200
  • Houston, TX 77055

Business Description

Not Available


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report May 31, 2016 10-Q
CIK 0000724445
Fiscal Year End 2/28
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2835 - Diagnostic substances
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Stanislaw R. Burzynski President
Dudley Anderson CFO
Patryk P. Goscianski Treasurer, Secretary
Company Directors
Stanislaw R. Burzynski Chairman
Company Notes
  • Formerly=Sundance International, Inc. to 7-84
Service Providers
Accounting/Auditing Firm
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
BZYR Security Details
Share Structure
Market Value1 $16,431,056 a/o Sep 23, 2016
Authorized Shares Not Available
Outstanding Shares 131,448,444 a/o May 31, 2013
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Shareholders
Shareholders of Record 2,009 a/o Jun 13, 2016
Short Selling Data
Short Interest 0 (-100%)
Jun 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security